Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

Describing Treatment of Primary Mediastinal Large B Cell Lymphoma Using Rigorously Defined Molecular Classification: A Retrospective Analysis

Carla Casulo, MD, Myla Strawderman, MS, Raphael Steiner, MD, Carolyne Delage, MD, Tina Faugh, Matthew J. Maurer, MS, Brian K. Link, MD, Allison C. Rosenthal, D.O., Colleen Ramsower, B.S. M.B., Richard Burack, MD PhD, Sergei Syrbu, MD PhD, Andrew L. Feldman, MD, Philip J Rock, James R. Cerhan, MD PhD, Christopher Flowers, MDMS, Lisa M. Rimsza, MD, Jonathan W. Friedberg, MD MSSc

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-143171

Published: 2020

Journal Articles

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

Jordan Krull, BS, Kerstin Wenzl, PhD, Michelle Manske, MS, BS, Melissa Hopper, MSc, Melissa C. Larson, MS, Vivekananda Sarangi, Matthew J. Maurer, MS, Zhi-Zhang Yang, PhD, Lisa M. Rimsza, MD, Brian K. Link, MD, Thomas M. Habermann, MD, Stephen M. Ansell, MD PhD, Rebecca L. King, MD, James R. Cerhan, MD PhD, Anne J. Novak, PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-142744

Published: 2020

Journal Articles

Over-Expression of Transferrin Receptor (TFRC/CD71) and Low Expression of Innate and Adaptive Immune Cell Subsets in HIV-Associated, GCB-DLBCL By Digital Gene Expression Profiling

Alanna Maguire, PhDMSc, Xianfeng Chen, BSc, Lee Wisner, A.A., Colleen Ramsower, B.S. M.B., Betty Glinsmann-Gibson, MS, Lisa M. Rimsza, MD

Blood (2019) 134 (Supplement_1): 2783.

https://doi.org/10.1182/blood-2019-129346

Published: 2019

Journal Articles

PET-Directed Therapy for Patients with Limited-Stage Diffuse Large B-Cell Lymphoma - Results of Intergroup Nctn Study S1001

Daniel O. Persky, MD, Hongli Li, MS, Deborah M. Stephens, DO, Steven I Park, MD, Nancy L. Bartlett, MD, Lode J. Swinnen, MB ChB, Paul M. Barr, MD, Jerome D. Winegarden, III, MD, Louis S. Constine, MD, Thomas J. Fitzgerald, MD, John P. Leonard, MD, Brad S. Kahl, MD, Michael L. Leblanc, PhD, Joo Y. Song, MD, Richard I. Fisher, MD, Lisa M. Rimsza, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2019) 134 (Supplement_1): 349.

https://doi.org/10.1182/blood-2019-123871

Published: 2019

Journal Articles

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study

N. Nora Bennani, MD, Grzegorz Nowakowski, MD, Lisa M. Rimsza, MD, Alex A Adjei, MD PhD, Laurence Doyle, Stephen M Ansell, MD PhD

Blood (2019) 134 (Supplement_1): 4090.

https://doi.org/10.1182/blood-2019-129104

Published: 2019

Journal Articles

Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel

Blood (2019) 134 (Supplement_1): 2769.

https://doi.org/10.1182/blood-2019-124352

Published: 2019

Journal Articles

Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of SWOG S0016

Richard Burack, MD PhD, Hongli Li, MS, Diana G Adlowitz, PhD, Janice M Spence, PhD, Michael L. Leblanc, PhD, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Catherine M. Spier, MD, Mark S Kaminski, MD, John P. Leonard, MD, Richard I. Fisher, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2019) 134 (Supplement_1): 2771.

https://doi.org/10.1182/blood-2019-121632

Published: 2019

Journal Articles

Subclonal Mutations of TP53 Are Common in Untreated Follicular Lymphoma and Mutation Status Is Predictive of PFS When CHOP Is Combined with 131-Iodine Tositumomab but Not with Rituximab: An Analysis of SWOG S0016

Richard Burack, MD PhD, Hongli Li, MS, Janice M Spence, PhD, Diana Adlowitz, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Catherine M. Spier, MD, Mark S Kaminski, MD, John P. Leonard, MD, Richard I. Fisher, MD, Michael L. Leblanc, PhD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2018) 132 (Supplement 1): 919.

https://doi.org/10.1182/blood-2018-99-111399

Published: 2018

Journal Articles

Long-Term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-Adapted Approach

Deborah M. Stephens, Hongli Li, MS, Heiko Schoder, MD, David J. Straus, MD, Craig H. Moskowitz, MD, Michael L. Leblanc, PhD, Lisa M. Rimsza, MD, Nancy L. Bartlett, MD, Andrew M. Evens, DO, MSc, Ann S. LaCasce, MD MSc, Paul Barr, MD, Michael V. Knopp, Eric D. Hsi, MD, John P. Leonard, MD, Brad S Kahl, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2018) 132 (Supplement 1): 929.

https://doi.org/10.1182/blood-2018-99-113034

Published: 2018

Journal Articles

Potential Impact of Consolidation Radiation Therapy for Advanced Hodgkin Lymphoma: A Secondary Modeling of SWOG S0816 with Receiver Operating Characteristic Analysis

Chul S. Ha, MD, Hongli Li, MS, Heiko Schoder, MD, Chelsea C Pinnix, MD, Elizabeth Brem, MD, Nancy L. Bartlett, MD, Andrew M. Evens, DO, MSc, Eric D. Hsi, MD, Lisa M. Rimsza, MD, John P. Leonard, MD, Brad S Kahl, MD, Michael L. Leblanc, PhD, Sonali M. Smith, MD, Louis S. Constine, MD, Jonathan W. Friedberg, MD

Blood (2018) 132 (Supplement 1): 2927.

https://doi.org/10.1182/blood-2018-99-113133

Published: 2018

Journal Articles

Clinical Features and Cell of Origin Subtyping Using Gene Expression Profiling in HIV-Negative Patients with Primary Central Nervous System Lymphoma

Talal Hilal, MBB Chir, Alanna Maguire, PhD MSc, Heidi E. Kosiorek, MS, Lisa M. Rimsza, MD, Allison C. Rosenthal, DO

Blood (2018) 132 (Supplement 1): 2977.

https://doi.org/10.1182/blood-2018-99-110660

Published: 2018

Journal Articles

Enhanced Expression of FGF Signaling in Primary Central Nervous System Lymphoma

Alanna Maguire, PhD MSc, Talal Hilal, MBBChir, Xianfeng Chen, BSc, Allison C. Rosenthal, DO, Lisa M. Rimsza, MD

Blood (2018) 132 (Supplement 1): 2847.

https://doi.org/10.1182/blood-2018-99-116416

Published: 2018

Journal Articles

Five-Year Outcomes of SWOG S1106: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Mantle Cell Lymphoma

Manali Kamdar, MD, Hongli Li, MS, Robert W. Chen, MD, Lisa M. Rimsza, MD, Michael L. Leblanc, PhD, Timothy S. Fenske, MD, Paul Barr, MD, Tycel J. Phillips, MD, John P. Leonard, MD, Brad S Kahl, MD, Jonathan W. Friedberg, MD, Sonali M. Smith, MD

Blood (2018) 132 (Supplement 1): 1593.

https://doi.org/10.1182/blood-2018-99-112752

Published: 2018

Journal Articles

Enhanced DNA Repair and Genomic Stability in HIV(+) Diffuse Large B Cell Lymphoma of Germinal Center Origin

Alanna Maguire, PhDMSc, Xianfeng Chen, BSc, Lee Wisner, A.A., Colleen Ramsower, B.S. M.B., Betty Glinsmann-Gibson, MS, Michael S. McGrath, MD PhD, Lisa M. Rimsza, MD

Blood (2018) 132 (Supplement 1): 1570.

https://doi.org/10.1182/blood-2018-99-116571

Published: 2018

Journal Articles

Prognostic Utility of Serum TARC, MDC, IL10, and Soluble CD163 Levels with Positron Emission Tomography (PET) Response-Adapted Therapy for Advanced-Stage Hodgkin Lymphoma (HL): a SWOG S0816 US Intergroup Correlative Study

Eric D. Hsi, MD, Hongli Li, MS, Andrew B. Nixon, PhD, Andrew M Evens, DO,MSc, Heiko Schoder, MD, David J. Straus, MD, Nancy L. Bartlett, MD, John William Sweetenham, MDFRCP, Paul M. Barr, MD, Michelle A. Fanale, MD, James R. Cook, MD PhD, Brad S Kahl, MD, John P. Leonard, MD, Sonali M. Smith, MD, Michael L. Leblanc, PhD, Lisa M. Rimsza, MD, Jonathan W. Friedberg, MD, Oliver W. Press, MD PhD

Blood (2017) 130 (Supplement 1): 4033.

https://doi.org/10.1182/blood.V130.Suppl_1.4033.4033

Published: 2017

Journal Articles

Characteristics and Outcomes of Patients with Double-Protein Expression in Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of SWOG Study S1001 (NCT01359592)

Deborah M. Stephens, DO, Hongli Li, MS, Daniel Persky, MD, Steven I. Park, MD, Nancy L. Bartlett, MD, Lode J. Swinnen, Carla Casulo, MD, Jerome D. Winegarden, III, MD, Louis S. Constine, MD, Thomas J. Fitzgerald, MD, John P. Leonard, MD, Brad S Kahl, MD, Michael L. Leblanc, PhD, Joo Y. Song, MD, Richard I. Fisher, MD, Lisa M. Rimsza, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2017) 130 (Supplement 1): 4122.

https://doi.org/10.1182/blood.V130.Suppl_1.4122.4122

Published: 2017

Journal Articles

Human Immunodeficiency Virus (HIV) Status Drives Diffuse Large B Cell Lymphoma through Oncogenic Signaling Pathways

Alanna Maguire, BSc, MSc, PhD, Gary B Fogel, PhD, Samantha L. Kendrick, PhD, Enoch S Liu, B.S., Lee Wisner, A.A., Colleen Ramsower, B.S. M.B., Betty Glinsmann-Gibson, MS, Susanna L Lamers, M.S., Michael S. McGrath, MD PhD, Lisa M. Rimsza, MD

Blood (2017) 130 (Supplement 1): 5128.

https://doi.org/10.1182/blood.V130.Suppl_1.5128.5128

Published: 2017

Journal Articles

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

Xiaoyu Qu, PhD, Hongli Li, MS, Oliver W. Press, MD PhD, Lisa M. Rimsza, MD, Rita M. Braziel, MD, Michael L. Leblanc, PhD, Eric D. Hsi, MD, John P. Leonard, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD, Min Fang, MDPhD

Blood (2017) 130 (Supplement 1): 1507.

https://doi.org/10.1182/blood.V130.Suppl_1.1507.1507

Published: 2017

Journal Articles

A Phase II Intergroup Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG Study S1001 (NCT01359592)

Daniel Persky, MD, Hongli Li, MS, Deborah M. Stephens, DO, Steven I. Park, MD, Nancy L. Bartlett, MD, Lode J. Swinnen, Paul M. Barr, MD, Jerome D. Winegarden, III, MD, Louis S. Constine, MD, Thomas J. Fitzgerald, MD, John P. Leonard, MD, Brad S Kahl, MD, Michael L. Leblanc, PhD, Joo Y. Song, MD, Richard I. Fisher, MD, Lisa M. Rimsza, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD

Blood (2017) 130 (Supplement 1): 1553.

https://doi.org/10.1182/blood.V130.Suppl_1.1553.1553

Published: 2017

Journal Articles

Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target

Blood (2016) 128 (22): 4095.

https://doi.org/10.1182/blood.V128.22.4095.4095

Published: 2016

NARROW

Describing Treatment of Primary Mediastinal Large B Cell Lymphoma Using Rigorously Defined Molecular Classification: A Retrospective Analysis

Global Transcriptional States of Follicular Lymphoma B Cells Highlight Distinct Groups of Tumor Identity Associated with Somatic Alterations and Tumor Microenvironment

Over-Expression of Transferrin Receptor (TFRC/CD71) and Low Expression of Innate and Adaptive Immune Cell Subsets in HIV-Associated, GCB-DLBCL By Digital Gene Expression Profiling

PET-Directed Therapy for Patients with Limited-Stage Diffuse Large B-Cell Lymphoma - Results of Intergroup Nctn Study S1001

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study

Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel

Intraclonal Heterogeneity Caused By Activation-Induced Cytidine Deaminase Is Not a Prognostic Biomarker in Untreated Advanced Stage Follicular Lymphoma: An Analysis of SWOG S0016

Subclonal Mutations of TP53 Are Common in Untreated Follicular Lymphoma and Mutation Status Is Predictive of PFS When CHOP Is Combined with 131-Iodine Tositumomab but Not with Rituximab: An Analysis of SWOG S0016

Long-Term Follow-up of SWOG S0816: Response-Adapted Therapy for Stage III/IV Hodgkin Lymphoma Demonstrates Limitations of PET-Adapted Approach

Potential Impact of Consolidation Radiation Therapy for Advanced Hodgkin Lymphoma: A Secondary Modeling of SWOG S0816 with Receiver Operating Characteristic Analysis

Clinical Features and Cell of Origin Subtyping Using Gene Expression Profiling in HIV-Negative Patients with Primary Central Nervous System Lymphoma

Enhanced Expression of FGF Signaling in Primary Central Nervous System Lymphoma

Five-Year Outcomes of SWOG S1106: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Mantle Cell Lymphoma

Enhanced DNA Repair and Genomic Stability in HIV(+) Diffuse Large B Cell Lymphoma of Germinal Center Origin

Prognostic Utility of Serum TARC, MDC, IL10, and Soluble CD163 Levels with Positron Emission Tomography (PET) Response-Adapted Therapy for Advanced-Stage Hodgkin Lymphoma (HL): a SWOG S0816 US Intergroup Correlative Study

Characteristics and Outcomes of Patients with Double-Protein Expression in Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of SWOG Study S1001 (NCT01359592)

Human Immunodeficiency Virus (HIV) Status Drives Diffuse Large B Cell Lymphoma through Oncogenic Signaling Pathways

Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016

A Phase II Intergroup Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL): SWOG Study S1001 (NCT01359592)

Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only